GlassScriptPhysician profile
Mayo Mitsuya
NPI 1164788386
$87,812.58
in general payments reported to CMS, 2019-2025
30 companies · $4,104 in 2025
The $4,104 reported for 2025 was more than what 89% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $5,426 · 2021: $31K · 2022: $10K · 2023: $8,374 · 2024: $17K · 2025: $4,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000 · Food and Beverage: $3,861 · Consulting Fee: $3,237 · Travel and Lodging: $2,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $16,000.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
| Food and Beverage | $3,860.66 |
| Consulting Fee | $3,237.40 |
| Travel and Lodging | $2,169.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $63,225.08 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Bioness INC | $14,694.62 | 2019-2021 | |
| Nalu Medical, INC. | $4,265.52 | 2021-2025 | Nalu Neurostimulation System |
| Zimmer Biomet Holdings, INC. | $1,608.58 | 2021-2023 | Ribfix Blu Advantage, Advantagerib |
| Medtronic, INC. | $932.78 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Medtronic USA, INC. | $876.02 | 2019-2020 | |
| Abbott Laboratories | $436.89 | 2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $298.23 | 2024 | Evoke |
| Daiichi Sankyo INC. | $172.76 | 2019 | |
| Nevro Corp. | $162.19 | 2019-2022 | |
| Kls-Martin L.P. | $149.05 | 2021-2023 | |
| Flowonix Medical Incorporated | $143.15 | 2019 | |
| Vertiflex, INC. | $127.86 | 2019 | |
| Baxter Healthcare | $99.52 | 2025 | Perclot |
| Vertos Medical, INC. | $94.13 | 2022-2024 | Mild Device Kit |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| 4web, INC. | $86.29 | 2019 | |
| Boston Scientific Corporation | $85.05 | 2019-2025 | Na, General - Pain Management |
| Tersera Therapeutics LLC | $78.74 | 2019 | |
| Ethicon US, LLC | $48.42 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $36.70 | 2019 | |
| Davol INC. | $30.42 | 2025 | Phasix Mesh |
| Relievant Medsystems, INC. | $25.17 | 2022 | |
| Pfizer INC. | $24.58 | 2019 | |
| Atricure, INC. | $22.38 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Bausch Health US, LLC | $22.18 | 2019 | |
| Merz North America, INC. | $18.68 | 2019 | |
| Biodelivery Sciences International, INC. | $12.91 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $12.01 | 2019 | |
| Depuy Synthes Sales INC. | $11.39 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mayo Mitsuya listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.